Caffeine Workflows for Cancer and Metabolic Research
2026-09-08
Caffeine supports reproducible concentration–response studies, VPA combination experiments, and metabolic phenotyping in diet-induced obesity mouse models. This guide pairs practical assay conditions with evidence boundaries and uses a recent ALDH2 activator study to improve controls without misattributing its cardiovascular findings to caffeine.
BIBR 1532: Designing Telomerase Mechanism Assays
2026-09-07
BIBR 1532 is a selective, non-nucleosidic telomerase inhibitor suited to experiments that separate acute hTERT inhibition from delayed telomere attrition and apoptosis. This guide translates recent CF10–EdU findings into practical assay-design decisions without conflating distinct DNA-damage mechanisms.
Fasudil (HA-1077) HCl: ROCK Workflows
2026-09-05
Fasudil (HA-1077) HCl provides a practical perturbation tool for connecting ROCK activity with cytoskeletal remodeling, migration, proliferation, and apoptosis. This guide translates its biochemical profile into reproducible cell-based workflows and shows how to use the compound cautiously when investigating ROCK–Hippo pathway relationships.
LIRP Enables Light-Controlled Translational Gene Therapy
2026-09-05
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that suppresses therapeutic mRNA translation in darkness and permits expression under blue or ambient light. By combining this switch with cell-based delivery and AAV vectors, the authors demonstrate remotely interruptible gene therapy concepts in obesity and retinal neovascular disease models.
NS1–DNMT1 Control of HBoV1 Replication and RNA Processing
2026-09-04
Qin et al. show that human bocavirus 1 (HBoV1) uses host DNA methylation and DNMT1 to support viral DNA synthesis while limiting viral RNA processing. The study further identifies NS1-mediated, proteasome-dependent DNMT1 degradation as a regulatory switch that promotes RNA maturation and viral protein expression.
Thiamet G Workflows for O-GlcNAc Research
2026-09-04
Thiamet G provides a practical, potent route to elevate protein O-GlcNAcylation in neuronal, cancer, differentiation, and stress-response assays. This guide translates its biochemical profile into dose-finding workflows, mechanistic controls, and a cautious extension to trophoblast ferroptosis research.
PP2A, Autophagy, and Candida Biofilm Drug Resistance
2026-09-03
The reference study identifies PP2A, encoded by PPH21, as a regulator of Candida albicans biofilm formation and drug resistance through Atg13 phosphorylation and downstream Atg1 activation. Its combination of genetic disruption, rapamycin-mediated autophagy activation, cellular assays, and an oral infection mouse model provides a mechanistic framework for understanding why biofilm-associated candidiasis responds poorly to antifungal therapy.
MK-1775 Workflow for Wee1 Checkpoint Studies
2026-09-02
Build more informative Wee1 inhibition experiments by separating growth arrest from cell killing and by testing MK-1775 with DNA-damaging agents in genotype-aware, time-resolved workflows. This approach helps distinguish target engagement, cell cycle checkpoint abrogation, and true chemosensitization in p53-deficient tumor models.
Realgar Toxicity, Ornithine, and Astrocyte Glycolysis
2026-09-02
The 2025 Advanced Science study links realgar-derived arsenic exposure to hepatic OTC inhibition, ornithine accumulation, and ZBTB7A-mediated suppression of astrocyte glycolysis in the frontal lobe. By combining conditional animal models, astrocyte experiments, single-cell transcriptomics, metabolomics, behavioral testing, and tissue analysis, it proposes a mechanistic liver–brain axis for realgar-induced CNS injury.
Mouse Neutrophil Cell Isolation Kit: Assay Design
2026-09-02
Learn how the Mouse Neutrophil Cell Isolation Kit supports low-perturbation, high-purity neutrophil assays. This guide translates recent neutrophil-targeted nanovaccine findings into practical sample, control, and workflow decisions.
DOPE Workflows for Nucleic Acid Delivery
2026-09-01
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is a membrane-fusion helper that can improve endosomal escape in cationic liposomes and LNPs. This practical guide connects formulation workflows with a recent Magnaporthe oryzae study, while clearly separating validated delivery applications from exploratory lipid-biology assays.
RISOTTO Study: Risedronate in RA-Related GIO
2026-08-31
The RISOTTO study tested sodium risedronate in 95 patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis using a six-month, multicentre, double-blind, placebo-controlled design. Risedronate produced a significantly greater increase in lumbar spine bone mineral density than placebo, supporting its role in osteoclast-mediated bone resorption inhibition while highlighting the need for longer fracture-focused studies.
PPT for ERα Signaling and LUAD Research
2026-08-31
Use PPT to separate ERα-driven transcription from ERβ activity, then connect receptor perturbation to FOXM1 and ceRNA hypotheses in female lung adenocarcinoma. This workflow combines selective pharmacology, controlled cell assays, and the uterotrophic assay for orthogonal validation.
Propranolol as a Translational Systems-Biology Lever
2026-08-30
Propranolol is more than a conventional cardiovascular tool: its non-selective β-adrenergic blockade connects receptor pharmacology with neurobehavioral, metabolic, and inflammatory biology. This thought-leadership article examines how burn-injury metabolomics strengthens the mechanistic case for Propranolol, then translates those findings into study-design principles, biomarker strategies, and reproducible workflows for cardiovascular regulation, emotional memory modulation, hypertension treatment, and essential tremor therapy.
Biomimetic Nanotherapy for Metastatic TNBC
2026-08-29
The reference study developed a cancer-cell-membrane-coated mesoporous silica nanoplatform that combines CuS-mediated photothermal ablation with R848-driven immune stimulation and tumor-localized anti-PD-1 peptide release. Its main significance is mechanistic integration: primary tumor destruction supplies antigens, while stimulus-responsive immune remodeling is used to address recurrence and metastasis in preclinical TNBC models.
461 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page